Growth Metrics

Novartis Ag (NVS) Free Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.06%
Dec 31, 2025 -38.65%
Sep 30, 2025 4.88%
Jun 30, 2025 10.75%
Mar 31, 2025 1.40%
Dec 31, 2024 75.60%
Sep 30, 2024 -2.10%
Jun 30, 2024 8.66%
Mar 31, 2024 -4.25%
Dec 31, 2023 73.29%
Sep 30, 2023 -2.42%
Jun 30, 2023 -1.97%
Mar 31, 2023 -8.22%
Dec 31, 2022 55.01%
Sep 30, 2022 -10.37%
Jun 30, 2022 0.50%
Mar 31, 2022 -5.66%
Dec 31, 2021 62.90%
Sep 30, 2021 -4.55%
Jun 30, 2021 58.30%
Mar 31, 2021 -8.57%
Dec 31, 2020 56.24%
Sep 30, 2020 -13.59%
Jun 30, 2020 2,266.28%
Mar 31, 2020 1,282.66%
Dec 31, 2019 1,309.04%
Sep 30, 2019 1,298.23%
Jun 30, 2019 2,109.34%
Mar 31, 2019 1,323.77%
Sep 30, 2018 1,211.95%
Jun 30, 2018 2,213.92%
Mar 31, 2018 1,290.12%
Sep 30, 2017 1,319.85%
Jun 30, 2017 2,203.12%
Mar 31, 2017 1,428.74%
Dec 31, 2016 1,394.88%
Sep 30, 2016 1,440.87%
Jun 30, 2016 1,481.38%
Mar 31, 2016 1,458.29%
Dec 31, 2015 1,520.90%
Sep 30, 2015 1,656.79%
Jun 30, 2015 9.78%
Mar 31, 2015 -33.52%
Dec 31, 2014 -96.31%
Sep 30, 2014 -28.48%
Jun 30, 2014 -26.98%
Mar 31, 2014 -26.97%